MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
3.400
+0.060 (1.80%)
At close: Apr 28, 2026, 4:00 PM EDT
3.390
-0.010 (-0.29%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
MiMedx Group Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for MiMedx Group stock have an average target of 9.00, with a low estimate of 7.00 and a high estimate of 12. The average target predicts an increase of 164.71% from the current stock price of 3.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MiMedx Group stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 1 | 1 | 1 | 2 |
| Buy | 1 | 2 | 2 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $10 → $7 | Buy | Maintains | $10 → $7 | +105.88% | Apr 20, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +105.88% | Apr 17, 2026 |
| Citizens | Citizens | Buy Initiates $10 | Buy | Initiates | $10 | +194.12% | Feb 23, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $12 → $8 | Buy | Maintains | $12 → $8 | +135.29% | Feb 17, 2026 |
| Lake Street | Lake Street | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +194.12% | Jan 20, 2026 |
Financial Forecast
Revenue This Year
351.95M
from 418.63M
Decreased by -15.93%
Revenue Next Year
397.78M
from 351.95M
Increased by 13.02%
EPS This Year
0.11
from 0.32
Decreased by -64.94%
EPS Next Year
0.23
from 0.11
Increased by 109.09%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 367.5M | 433.1M | |||
| Avg | 352.0M | 397.8M | |||
| Low | 333.2M | 365.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -12.2% | 23.1% | |||
| Avg | -15.9% | 13.0% | |||
| Low | -20.4% | 3.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.19 | 0.32 | |||
| Avg | 0.11 | 0.23 | |||
| Low | 0.04 | 0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -40.9% | 180.7% | |||
| Avg | -64.9% | 109.1% | |||
| Low | -87.7% | 31.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.